ዛኑብሩቲኒብ በዩኤስኤፍዲኤ ለድጋሚ ላገረሸ ወይም ለሚያድግ ፎሊኩላር ሊምፎማ ጸድቋል

March 2024: Zanubrutinib (Brukinsa, BeiGene USA, Inc.) in combination with obinutuzumab has been granted accelerated approval by the Food and Drug Administration for the treatment of relapsed or refractory follicular lymphoma (FL)..

በሊምፎማ ሕክምና ውስጥ የበሽታ መከላከያ ሕክምና ሚና

If you're reading this, you or maybe one of your loved ones is on a journey that no one ever plans to take—the path of facing cancer. We understand that this road is filled with uncertainties, fears, and moments when it feel..

መኪና - ቲ ሴል ቴራፒ, የ CAR ቲ ሕክምና, የመኪና ቲ-ሴል, ቺሜሪክ ወኪል

ወደ CAR T የሕዋስ ሕክምና ጥልቅ ዘልቆ መግባት፡ እንዴት ነው የሚሰራው?

በህንድ ውስጥ ከCAR T የሕዋስ ሕክምና ሕክምና በስተጀርባ ያለውን ሳይንስ ያግኙ! ይህ አብዮታዊ ህክምና የእርስዎን በሽታ የመከላከል ሴሎች ወደ የካንሰር ተዋጊዎች እንዴት እንደሚቀይር ያስሱ። ስለዚህ ተአምራዊ ህክምና እና እንዴት እንደሆነ የበለጠ ለማወቅ ጦማራችንን አሁን ያንብቡ።

የመኪና ቲ-ሴል, የ CAR ህክምና, immunotherapy, የቲ ሴል ሕክምና

የ CAR ቲ-ሴል ሕክምና በህንድ ውስጥ ይገኛል?

Have you ever wondered if there is a powerful way to fight cancer? Now just imagine if one day you found a ray of hope in your fight against cancer, a treatment that uses the power of your body's own immune system to target an..

ቢ-ሴል ሊምፎማ, ዲኤልቢሲኤል, ፖላሪክስ, ፖላቱዙማብ, polatuzumab vedotin

Polatuzumab vedotin-piiq ቀደም ሲል ህክምና ላልተደረገለት ትልቅ ቢ-ሴል ሊምፎማ እና ከፍተኛ ደረጃ B-cell ሊምፎማ በUSFDA ጸደቀ።

ሜይ 2023፡ ለአዋቂ ታካሚዎች ከፍተኛ ደረጃ ቢ-ሴል ሊምፎማ (HGBL) በሌላ መልኩ ያልተገለፀ (NOS)፣ ወይም ትልቅ ቢ-ሴል ሊምፎማ (ዲኤልቢሲኤል) ከዚህ ቀደም ህክምና ያላገኙ እና አለም አቀፍ ፕሮግኖስቲክ ኢንዴ ያላቸው።

ካርቴቫ, ጄደብሊው ቴራፒዩቲክስ, ሊምፎማ, እምቢተኛ የ follicular lymphoma, RELIANCE ጥናት, relmacabtagene autoleucel

JW Therapeutics NMPA የ Relmacabtagene Autoleucel መርፌን ማፅደቁን ያስታውቃል ያገረሽ ወይም ፎሊኩላር ሊምፎማ ባለባቸው ታካሚዎች

SHANGHAI, CHINA, October 10, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing, and commercializing cell immunotherapy products, announced that the Na..

ASTCT, CIBMTR, ትልቅ ቢ-ሴል ሊምፎማ, ማቲው ፍራንክ, ሚልቴኒ ባዮቴክ, ስታንፎርድ ዩኒቨርሲቲ

ከCAR-T ሕክምና በኋላ ለሚያገረሽ የሊምፎማ ሕመምተኞች አዲስ ሕክምና ዒላማ

Feb 2023: The results of the trial demonstrated that a novel chimeric antigen receptor T-cell therapy elicited a response in adults with advanced large B-cell lymphoma who had relapsed following prior CAR-T. According to stati..

ኤሊ ሊሊ እና ኩባንያ, ኤፍዲኤ, የምግብ እና የመድሃኒት አስተዳደር, ጃይፒርካ, Mantle cell lymphoma, ኤም.ሲ.ኤል., pirtobrutinib

የተፋጠነ ማጽደቅ በኤፍዲኤ ለፒርቶብሩቲኒብ ለዳግም ላገረሰ ወይም ለማጣቀሻ የማንትል ሴል ሊምፎማ ተሰጥቷል

Feb 2023: Accelerated approval is granted by FDA to pirtobrutinib (Jaypirca, Eli Lilly and Company) for relapsed or refractory mantle cell lymphoma. In BRUIN (NCT03740529), an open-label, multicenter, single-arm trial of pirtobr..

ቤይጂን አሜሪካ, ብሩኪንሳ, ሥር የሰደደ የሊምፍ ኖስቲክ በሽታ, ሰሜናዊ, ትንሽ ሊምፎይቲክ ሊምፎማ

Zanubrutinib ሥር የሰደደ ሊምፎይቲክ ሉኪሚያ ወይም ትንሽ ሊምፎይቲክ ሊምፎማ በ FDA ጸድቋል

Feb 2023: Zanubrutinib (Brukinsa, BeiGene USA, Inc.) is approved by FDA for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). SEQUOIA was used to assess effectiveness in CLL/SLL patients who had not recei..

አድኪትሪስ, ብሬንቱክሲማብ ቬዶቲን, ክላሲካል ሆጅኪን ሊምፎማ, ሲገን ኢንክ

ብሬንቱክሲማብ ቬዶቲን ክላሲካል ሆጅኪን ሊምፎማ ላለባቸው የሕፃናት ሕመምተኞች ከኬሞቴራፒ ጋር በማጣመር በኤፍዲኤ ተቀባይነት አግኝቷል

እ.ኤ.አ. ኖቬምበር 2022፡ የዶክሶሩቢሲን፣ vincristine፣ etoposide፣ prednisone እና cyclophosphamide ከ brentuximab vedotin (Adcetris፣ Seagen, Inc.) ጋር ጥምረት በምግብ እና መድሀኒት አስተዳደር በልጆች ላይ እንዲውል ጸድቋል።